The t(2;14)(p13;q32.3) involving the BCL11A and IGH genes is a rare but recurrent chromosomal aberration in B-cell malignancies. Hitherto, juxtaposition of BCL11A and IGH has only been described in B-cell chronic lymphocytic leukemia (B-CLL) and immunocytoma. As subgroups of B-CLL can be distinguished by the pattern of somatic mutation of immunoglobulin variable (V) genes we investigated four lymphomas with IGH/BCL11A involvement for IGH hypermutation. Clonal V H gene rearrangements were amplified; in all four cases, sequencing of the amplificates revealed the rearranged V H genes to lack somatic mutations. These results suggest that t(2;14)(p13;q32.3) is associated with a subset of B-CLL/immunocytoma characterized by non-mutated IG genes deriving from pre-germinal center B cells. As the translocations in both informative cases are targeted to the switch regions of the IGG2 gene, which is mainly used in T cell-independent immune responses, these translocations presumably occurred in activated B cells in the course of T cell-independent immune responses outside the germinal center. Leukemia (2002) 16, 937-939.
Introduction
Malignant transformation of B cells can occur at various steps of lymphocyte development, starting from early B cell progenitors up to mature B cells. Consequently, B cell neoplasms are remarkably heterogeneous with regard to their biological and clinical behavior. 1 The genetic characterization of B cell neoplasms has not only contributed to our current understanding of B cell lymphomagenesis but also to a more precise definition of lymphoma subgroups as reflected in the upcoming WHO classification. 1 Recurrent primary chromosomal abnormalities, in particular those affecting the IGH locus in chromosome region 14q32, have been repeatedly shown to be associated with distinct subtypes of B lymphoid neoplasms and are, thus, used as diagnostic markers. Well-established examples are the t(8;14), t(14;18) and t (11;14) translocations associated with Burkitt lymphoma, follicular lymphoma, and mantle cell lymphoma, respectively. 2 Recently, we reported juxtaposition of a novel Krü ppel zinc finger gene, BCL11A, next to the IGH locus by a recurrent t(2;14)(p13;q32.3) in four cases of B cell malignancies. 3 Remarkably, in three of the four patients the t(2;14)(p13;q32.3) was the sole aberration in a subset or all of the metaphases analyzed indicating that this translocation was the primary cytogenetic abnormality. Considering that juxtaposition of IGH and BCL11A genes has so far only been detected in cases diagnosed as B cell chronic lymphocytic leukemia (B-CLL) or immunocytoma (IC) it is intriguing to speculate that the t(2;14)(p13;q32.3) translocation might be the characteristic chromosomal change of a group of leukemic B lymphocytic neoplasms. 3 Growing evidence suggests that the category of B-CLL and small lymphocytic lymphoma contains several different disease subtypes, which can be distinguished as to cytogenetic features, antigen expression patterns and clinical course. 1, [4] [5] [6] Moreover, considerable differences in the frequency of somatic hypermutation within the IG variable (V) region genes points to the existence of at least two groups of B-CLL: one group with unfavorable prognosis characterized by unmutated IG genes is supposed to be derived from pre-germinal center B cells; the second group with more favorable prognosis has mutated IG genes and is assumed to be originated from postgerminal center B cells. 4, 7 In order to investigate the histogenetic derivation of the B cell neoplasms with t(2;14)(p13;q32.3) we analyzed four cases of B-CLL/IC with proven IGH and BCL11A involvement for somatic mutation of the rearranged V H genes.
Materials and methods

Patient material
Four patients with CLL and t(2;14)(p13;q32) were studied. In one of them (patient K) the clinical diagnosis of CLL was established but a lymph node biopsy was consistent with a lymphoplasmacytic immunocytoma. Clinical details on all patients have been published previously. 3, 8, 9 DNA amplification and sequence analysis V H gene rearrangements were amplified from genomic DNA isolated from frozen tissue using a set of six V H family-specific primers and a J H primer mix. Sequences of V H framework region I primers and the 3′ J H primer mix have been described. 10 The V H 1 primer was replaced by 5′ CAG TCT GGG GCT GAG GTG AAG A 3′. PCR was carried out for 40 cyles. PCR products were gel-purified and directly sequenced using the V H PCR primers and the BigDye Terminator cycle sequencing kit (PE Applied Biosystems, Weiterstadt, Germany). Sequences were analyzed on an ABI377 automated sequencer (PE Applied Biosystems).
Results and discussion
Four cases of B cell malignancies with a t(2;14)(p13;q32.3) were studied for somatic hypermutation of the rearranged IGH Leukemia V genes. These included two unusual pediatric patients (cases AS and LH) 8, 9 and an adult patient (case B) with B-CLL. Moreover, a second adult patient (case K) with the clinical diagnosis of CLL was investigated, in which a lymph node biopsy was diagnostic for a lymphoplasmacytic immunocytoma expressing monoclonal IgM. Tumor cells of all four cases expressed the CD5 antigen, as expected for B-CLL (not shown). By molecular cloning (AS, LH, K) or Southern blot (B) as well as by fluorescence in situ hybridization (FISH) we previously showed that the t(2;14)(p13;q32.3) affects the BCL11A and IGH loci in 2p13 and 14q32.3, respectively, in these cases. 3 In all four tumors IGH breaks occurred within S␥ regions, whilst the 2p13 breaks clustered centromeric of a CpG island associated with the 5′ end of the BCL11A gene. 3 The S␥ regions at the translocation breakpoints were analyzed in two of the cases in a previous study and identified as S␥2 in both instances ( (Table 1) . J H 4 and J H 6, the two most frequently used J H gene segments, were each used in two V H rearrangements (Table 1) . All rearranged V H genes were potentially functional as they were rearranged in the correct reading frame and lacked stop codons in complementarity determining region (CDR) III. The four V H genes were all unmutated as they showed 100% homology to the most homologous germline genes (Table 1) .
Concluding remarks
B-CLL can be distinguished into two subgroups based on the presence or absence of somatic mutations in their rearranged IG genes. 4, 7, 12 Importantly, these subsets also differ in their clinical behaviour, as patients with unmutated IG genes in the B-CLL clone have a worse prognosis. 4, 7 Recently, reciprocal chromosomal translocations involving the BCL11A gene were identified as a recurrent aberration in a small number of cases. The sequences described in this paper have been deposited in the EMBL database: AJ428926-AJ428929. The data for IG expression and the IGH constant region gene involved in the BCL11A translocation are taken from Refs 3 and 11. For the other cases, these data are not available. ND, not determined.
We wanted to find out whether this translocation was associated with one of the two subsets of B-CLL and therefore sequenced the rearranged IGH genes. It turned out that all four cases analyzed harbored unmutated V H genes, indicating that BCL11A aberrations are associated with the subset of unmutated B-CLL. This finding is remarkable as BCL11A is predominantly expressed in germinal center cells, 3 suggesting that the translocation results in aberrant expression of this gene in B cells at a pre-germinal center stage of development.
The lack of somatic mutations in the rearranged IG genes is suggestive of a derivation of the tumor cells from pre-germinal center B cells, which are mostly naive, ie antigen-unexperienced. However, the involvement of the C␥ switch regions in the translocation events of BCL11A in the four cases is suggestive of antigen activation of the tumor precursor, as translocations involving IGH switch regions presumably happen as a mistake during an attempted class switch recombination (reviewed in Ref. 13) , which is a process that occurs only in activated B cells.
14 Although most class switching takes place in the germinal center, 15 it is well known that also in T cellindependent immune responses not involving germinal centers, class switch recombination can take place.
14 Intriguingly, in both of the two cases in which the switch C␥ regions involved in the translocation could be identified (cases AS and LH), the translocation breakpoints are at the C␥2 gene, which is the IGH gene preferentially expressed in T cell-independent immune responses 16, 17 (Notably, the translocations in AS and LH are in both cases on the productive IGH allele. 11, 18 The tumor cells express IgM, 11, 18 likely driven by the IGH intron enhancer, which is translocated to 2p
− together with the IGH rearrangement and the C gene.) Hence, the generation of the BCL11A translocations in B-CLL and IC may be related to antigenic activation of the tumor precursors in the context of T cell-independent immune responses associated with an attempted class switch recombination to IGG2. In line with this idea, it has been suggested that CD5-positive B cells, which may represent the normal counterpart of (unmutated) CD5-positive B-CLL, are mainly involved in T cell-independent immune responses. 19, 20 A potential role of activation by (foreign or auto-) antigen in unmutated B-CLL has also been speculated by others. 4 Taken together, B-CLL carrying chromosomal translocations involving the BCL11A gene in most, if not all, cases belong to the subset of B-CLL with unmutated V genes and hence presumably a germinal center-independent development. The involvement of the IGH switch region in the translocations, nevertheless, indicates antigen-triggering in the history of the tumor clone, likely involving a T cell-independent immune response.
